Mutations in the human connexin gene GJB3 cause erythrokeratodermia variabilis

被引:268
作者
Richard, G
Smith, LE
Bailey, RA
Itin, P
Hohl, D
Epstein, EH
DiGiovanna, JJ
Compton, JG
Bale, SJ [1 ]
机构
[1] NIAMSD, Genet Studies Sect, Skin Biol Lab, NIH, Bethesda, MD 20892 USA
[2] Univ Basel, Dept Dermatol, Basel, Switzerland
[3] Beaumont Hosp, Dept Dermatol, Lausanne, Switzerland
[4] Univ Calif San Francisco, San Francisco Gen Hosp, Dept Dermatol, San Francisco, CA 94143 USA
[5] Brown Univ, Rhode Isl Hosp, Dept Dermatol, Div Dermatopharmacol, Providence, RI 02903 USA
关键词
D O I
10.1038/3840
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Erythrokeratodermia variabilis (EKV, OMIM 133200) is an autosomal dominant genodermatosis with considerable intra- and interfamilial variability(1). It has a disfiguring phenotype characterized by the independent occurrence of two morphologic features: transient figurate red patches and localized or generalized hyperkeratosis (Fig. 1). Both features can be triggered by external factors such as trauma to the skin. After initial linkage to the RH locus on 1p (refs 2,3). EKV was mapped to an an interval of 2.6 cM on 1p34-p35. and a candidate gene (GJA4) encoding the gap junction protein alpha-4 (connexin 31. Cx31) was excluded by sequence analysis(4). Evidence in mouse suggesting that the EKV region harbours a cluster of epidermally expressed connexin genes(5,6) led us to characterize the human homologues of GJB3 (encoding Cx31) and GJB5 (encoding Cx31.1). GJB3, GJB5 and GJA4 were localized to a 1.1-Mb YAC in the candidate interval. We detected heterozygous missense mutations in GJB3 in four EKV families leading to substitution of a conserved glycine by charged residues (G12R and G12D). or change of a cysteine (C865). These mutations are predicted to interfere with normal Cx31 structure and function, possibly due to a dominant inhibitory effect. Our results implicate Cx31 in the pathogenesis of EKV, and provide evidence that intercellular communication mediated by Cx31 is crucial for epidermal differentiation and response to external factors.
引用
收藏
页码:366 / 369
页数:4
相关论文
共 30 条
[1]   CONNEXIN MUTATIONS IN X-LINKED CHARCOT-MARIE-TOOTH DISEASE [J].
BERGOFFEN, J ;
SCHERER, SS ;
WANG, S ;
SCOTT, MO ;
BONE, LJ ;
PAUL, DL ;
CHEN, K ;
LENSCH, MW ;
CHANCE, PF ;
FISCHBECK, KH .
SCIENCE, 1993, 262 (5142) :2039-2042
[2]   SWITCH IN GAP JUNCTION PROTEIN EXPRESSION IS ASSOCIATED WITH SELECTIVE CHANGES IN JUNCTIONAL PERMEABILITY DURING KERATINOCYTE DIFFERENTIATION [J].
BRISSETTE, JL ;
KUMAR, NM ;
GILULA, NB ;
HALL, JE ;
DOTTO, GP .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1994, 91 (14) :6453-6457
[3]   Connections with connexins: The molecular basis of direct intercellular signaling [J].
Bruzzone, R ;
White, TW ;
Paul, DL .
EUROPEAN JOURNAL OF BIOCHEMISTRY, 1996, 238 (01) :1-27
[4]  
BUTTERWECK A, 1994, EUR J CELL BIOL, V65, P152
[5]  
DACOSTA SM, 1925, ACTA DERM-VENEREOL, V6, P255
[6]   Prelingual deafness: high prevalence of a 30delG mutation in the connexin 26 gene [J].
Denoyelle, F ;
Weil, D ;
Maw, MA ;
Wilcox, SA ;
Lench, NJ ;
AllenPowell, DR ;
Osborn, AH ;
Dahl, HHM ;
Middleton, A ;
Houseman, MJ ;
Dode, C ;
Marlin, S ;
BoulilaElGgaied, A ;
Grati, M ;
Ayadi, H ;
BenArab, S ;
Bitoun, P ;
LinaGranade, G ;
Godet, J ;
Mustapha, M ;
Loiselet, J ;
ElZir, E ;
Aubois, A ;
Joannard, A ;
Levilliers, J ;
Garabedian, EN ;
Mueller, RF ;
Gardner, RJM ;
Petit, C .
HUMAN MOLECULAR GENETICS, 1997, 6 (12) :2173-2177
[7]  
Deschenes SM, 1997, J NEUROSCI, V17, P9077
[8]   EXPRESSION OF GAP JUNCTION PROTEINS CX26, CX31.1, CX37, AND CX43 IN DEVELOPING AND MATURE RAT EPIDERMIS [J].
GOLIGER, JA ;
PAUL, DL .
DEVELOPMENTAL DYNAMICS, 1994, 200 (01) :1-13
[9]   Connexins, connexons, and intercellular communication [J].
Goodenough, DA ;
Goliger, JA ;
Paul, DL .
ANNUAL REVIEW OF BIOCHEMISTRY, 1996, 65 :475-502
[10]   GAP-JUNCTIONAL PROTEIN CONNEXIN-43 IS EXPRESSED IN DERMIS AND EPIDERMIS OF HUMAN SKIN - DIFFERENTIAL MODULATION BY RETINOIDS [J].
GUO, HM ;
ACEVEDO, P ;
PARSA, FD ;
BERTRAM, JS .
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1992, 99 (04) :460-467